PharmaVentures’ 1-1 Partnering Clinic is a unique opportunity for BayBio2007 delegates to receive bespoke advice from PharmaVentures, experts in deals and alliances.

Do you have questions relating to licensing, deal structure, business strategy and partnering opportunities?

If the answer is yes, then take advantage of this special opportunity to gain expert advice from PharmaVentures – exclusively for BayBio delegates.

The PharmaVentures Partnering Clinic, open through the course of the conference, will provide delegates, who are attending the BayBio AGM on 26 April in San Francisco, with the opportunity to book their free one-to-one consulting session with Jim McCarthy of PharmaVentures.

Jim McCarthy, VP Corporate Development, has thirty years of life sciences professional experience. His background includes a 24-year career with Bristol-Myers Squibb, and positions with Eli Lilly & Company and the Arthur Young Health Care Consulting Group.

Jim has spent over a dozen years in corporate business development and external growth roles with pharmaceutical, medical device and ethical nutrition businesses and his experience spans work in over 30 countries, across a range of external growth alliance transactions (i.e. acquisitions, divestitures, licensing, research agreements etc).

Jim McCarthy is available to discuss the following topics:

• Business plan review
• Review of licensing deal in play
• Review of deal structure
• Partnering opportunities
• North American/European deal making perspectives or advice
• Engaging with Big Pharma
• Effective presentations to investors and partners
• Deal flow: Effective process and productivity

Due to limited availability, ensure you book your session today.

• Click here to arrange a meeting.

About PharmaVentures

A leading results driven organisation, PharmaVentures (www.pharmaventures.com) assists pharmaceutical and biotechnology companies across the world in all aspects of deal making. It provides tailored consulting services and adds value to deals through the PharmaDeals range of intelligence products which includes analysis tools, reports and workshops.

An innovative business, PharmaVentures provides industry information and advice through the world's first online pharmaceutical television show www.pharmatelevision.com. Now in its 10th year PharmaVentures is based in Oxford, UK, employs 45 people mostly educated to PhD or above, and has increased its turnover fivefold, with 80% coming from outside the UK. With offices in the US and the UK, PharmaVentures works for a variety of clients from start-ups to global corporate pharmaceutical companies.

Our consultants, analysts and business researchers have the flexibility to support your short and long-term goals, from the grand corporate vision to the essential technical details. This might include working alongside you to investigate the potential of a new market opportunity; identifying worldwide products and technologies for in-licensing; identifying target companies for mergers; or investigating beneficial strategic partnerships. Consultancy projects that we have undertaken include:

• Commercial strategy development
• Product / company / market analysis evaluation
• Valuation, deal strategy and negotiation
• Due diligence / expert reports
• Portfolio assessment
• Deal making and partnering
• Litigation / expert witness
• Opportunity screening
• Business planning
• Forecasting

By relying on us to take care of your planning and development, you can concentrate on running your core business, secure in the knowledge that we are handling all the deal-based aspects of your future strategy.